Back to Search
Start Over
GLP-1 agonist treatment: implications for diabetic retinopathy screening.
- Source :
-
Diabetes research and clinical practice [Diabetes Res Clin Pract] 2011 Dec; Vol. 94 (3), pp. e68-71. Date of Electronic Publication: 2011 Sep 08. - Publication Year :
- 2011
-
Abstract
- Rapid improvement in glycaemic control induced by GLP-1 agonist therapy could be yet another illustration of transient or permanent progression of diabetic retinopathy, similar to documented examples such as pregnancy and continuous subcutaneous insulin infusion. Specific guidelines would be needed to monitor this paradoxical phenomenon during treatment with GLP-1 agonists.<br /> (Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.)
- Subjects :
- Adult
Aged
Diabetes Complications diagnosis
Diabetic Retinopathy etiology
Female
Humans
Insulin Infusion Systems
Male
Mass Screening
Middle Aged
Pregnancy
Pregnancy in Diabetics etiology
Prognosis
Retrospective Studies
Diabetes Complications drug therapy
Diabetes Mellitus, Type 2 drug therapy
Diabetic Retinopathy diagnosis
Glucagon-Like Peptide 1 agonists
Glucagon-Like Peptide 1 therapeutic use
Pregnancy in Diabetics diagnosis
Subjects
Details
- Language :
- English
- ISSN :
- 1872-8227
- Volume :
- 94
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Diabetes research and clinical practice
- Publication Type :
- Academic Journal
- Accession number :
- 21906831
- Full Text :
- https://doi.org/10.1016/j.diabres.2011.08.017